Comparing the effect of memantine tablets with placebo in reducing pain after abdominal surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240120060739N1

Enrollment

Registered

2024-12-08

Start date

2022-09-06

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pain. Acute pain

Interventions

Intervention 1: Intervention group: Receives memantine tablets upon entry to the operating room and in the recovery room. Intervention 2: Control group: The second group takes placebo (100 mg vitamin

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age 15-75 years Electiveness of surgery

Exclusion criteria

Exclusion criteria: The operation lasts more than 4 hours Abnormal bleeding during surgery

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: 1,6,12,24 hours after surgery. Method of measurement: VAS.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Hassan Mohajeri

Islamic Azad University

aliiabdolmalekii@yahoo.com+98 21 2660 2642

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026